BK vs TARS · P/E 17, $94.14B cap vs rev $336.0M
The Bank of New York Mellon Corporation (BK) versus Tarsus Pharmaceuticals Inc (TARS) — a side-by-side from cached financials, not a winner call.
The Bank of New York Mellon Corporation (BK) is a banks - diversified company listed on US.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
BK does not have a complete income-statement cache yet.
Latest reported TARS revenue for 2026-06-30 was $336.0M. Net income was -$25.5M. TARS currently screens at market cap $2.66B.
BK currently screens at market cap $94.14B and trailing P/E 17.0. TARS currently screens at market cap $2.66B.
Not investment advice. Open the BK and TARS stock pages for the full models.
Not investment advice.